Dihydroartemisinin inhibits angiogenesis in breast cancer via regulating VEGF and MMP‐2/‐9

Qi Rao(Huanggang Central Hospital), Fenghua Wu(Hubei University of Chinese Medicine), Gang Zhao(Hubei University of Chinese Medicine), Xiaohong Guo(University of Medical Sciences and Technology), Yuxue Wang(Southwest University), Ruochan Li(Hubei University of Chinese Medicine), Yu He(Hubei University of Chinese Medicine), Bin He(Blood Center of Zhejiang Province)
Fundamental and Clinical Pharmacology
July 25, 2023
10.1111/fcp.12941
Cited by 31

Related Papers

DDX17 induces epithelial-mesenchymal transition and metastasis through the miR-149-3p/CYBRD1 pathway in colorectal cancer
|Cell Death and Disease|2023|101
The HDAC Inhibitor Quisinostat (JNJ-26481585) Supresses Hepatocellular Carcinoma alone and Synergistically in Combination with Sorafenib by G0/G1 phase arrest and Apoptosis induction
|International Journal of Biological Sciences|2018|45
MicroRNA-155 promotes the proliferation and invasion abilities of colon cancer cells by targeting quaking
|Molecular Medicine Reports|2014|37
Berberine exerts its antineoplastic effects by reversing the Warburg effect via downregulation of the Akt/mTOR/GLUT1 signaling pathway
|Oncology Reports|2021|26
Effects of dihydroartemisinin combined with cisplatin on proliferation, apoptosis and migration of HepG2 cells
|Oncology Letters|2022|12